BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 26047946)

  • 21. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
    Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
    PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alk2/ACVR1 and Alk3/BMPR1A Provide Essential Function for Bone Morphogenetic Protein-Induced Retinal Angiogenesis.
    Lee HW; Chong DC; Ola R; Dunworth WP; Meadows S; Ka J; Kaartinen VM; Qyang Y; Cleaver O; Bautch VL; Eichmann A; Jin SW
    Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):657-663. PubMed ID: 28232325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring?
    Andreev K; Zenkel M; Kruse F; Jünemann A; Schlötzer-Schrehardt U
    Exp Eye Res; 2006 Nov; 83(5):1162-70. PubMed ID: 16879818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
    You L; Kruse FE
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rodent adrenocortical cells display high affinity binding sites and proteins for inhibin A, and express components required for autocrine signalling by activins and bone morphogenetic proteins.
    Farnworth PG; Wang Y; Leembruggen P; Ooi GT; Harrison C; Robertson DM; Findlay JK
    J Endocrinol; 2006 Mar; 188(3):451-65. PubMed ID: 16522726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMPR-II is dispensable for formation of the limb skeleton.
    Gamer LW; Tsuji K; Cox K; Capelo LP; Lowery J; Beppu H; Rosen V
    Genesis; 2011 Sep; 49(9):719-24. PubMed ID: 21538804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Activation of the Fibrodysplasia Ossificans Progressiva-Inducing ALK2-R206H Mutant Depends on the Distinct Homo-Oligomerization Patterns of ACVR2B and ACVR2A.
    Szilágyi SS; Burdzinski W; Jatzlau J; Ehrlich M; Knaus P; Henis YI
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle.
    Kayani AR; Glister C; Knight PG
    Reproduction; 2009 Jan; 137(1):67-78. PubMed ID: 18936084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cripto forms a complex with activin and type II activin receptors and can block activin signaling.
    Gray PC; Harrison CA; Vale W
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5193-8. PubMed ID: 12682303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mRNA expression of type I and type II receptors for activin, transforming growth factor-beta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.fl.
    Machida H; Ogawa K; Funaba M; Mizutani T; Tsujimoto M
    Eur J Endocrinol; 2000 Nov; 143(5):705-10. PubMed ID: 11078996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LbetaT2 cells.
    Takeda M; Otsuka F; Otani H; Inagaki K; Miyoshi T; Suzuki J; Mimura Y; Ogura T; Makino H
    J Endocrinol; 2007 Jul; 194(1):87-99. PubMed ID: 17592024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
    Glister C; Kemp CF; Knight PG
    Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibin is an antagonist of bone morphogenetic protein signaling.
    Wiater E; Vale W
    J Biol Chem; 2003 Mar; 278(10):7934-41. PubMed ID: 12493742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibins differentially antagonize activin and bone morphogenetic protein action in a mouse adrenocortical cell line.
    Farnworth PG; Stanton PG; Wang Y; Escalona R; Findlay JK; Ooi GT
    Endocrinology; 2006 Jul; 147(7):3462-71. PubMed ID: 16601134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass.
    Goh BC; Singhal V; Herrera AJ; Tomlinson RE; Kim S; Faugere MC; Germain-Lee EL; Clemens TL; Lee SJ; DiGirolamo DJ
    J Biol Chem; 2017 Aug; 292(33):13809-13822. PubMed ID: 28659341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory roles of bone morphogenetic proteins and glucocorticoids in catecholamine production by rat pheochromocytoma cells.
    Kano Y; Otsuka F; Takeda M; Suzuki J; Inagaki K; Miyoshi T; Miyamoto M; Otani H; Ogura T; Makino H
    Endocrinology; 2005 Dec; 146(12):5332-40. PubMed ID: 16150914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin receptor signaling: a potential therapeutic target for osteoporosis.
    Lotinun S; Pearsall RS; Horne WC; Baron R
    Curr Mol Pharmacol; 2012 Jun; 5(2):195-204. PubMed ID: 21787285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACVR2A promoter polymorphism rs1424954 in the Activin-A signaling pathway in trophoblasts.
    Thulluru HK; Michel OJ; Oudejans CB; van Dijk M
    Placenta; 2015 Apr; 36(4):345-9. PubMed ID: 25659497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin.
    Xia Y; Babitt JL; Sidis Y; Chung RT; Lin HY
    Blood; 2008 May; 111(10):5195-204. PubMed ID: 18326817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal regulation of mRNAs for select bone morphogenetic proteins (BMP), BMP receptors and their associated SMAD proteins during bovine early embryonic development: effects of exogenous BMP2 on embryo developmental progression.
    Lee KB; Folger JK; Rajput SK; Smith GW
    Reprod Biol Endocrinol; 2014 Jul; 12():67. PubMed ID: 25027287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.